HBW Advisory Services’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $963K | Buy |
2,376
+46
| +2% | +$18.7K | 0.12% | 172 |
|
|
2025
Q1 | $1.16M | Buy |
2,330
+93
| +4% | +$46.3K | 0.16% | 125 |
|
|
2024
Q4 | $1.16M | Buy |
2,237
+1
| +0% | +$520 | 0.12% | 125 |
|
|
2024
Q3 | $1.38M | Sell |
2,236
-9
| -0.4% | -$5.57K | 0.2% | 114 |
|
|
2024
Q2 | $1.24M | Sell |
2,245
-34
| -1% | -$18.8K | 0.21% | 120 |
|
|
2024
Q1 | $1.21M | Hold |
2,279
| – | – | 0.23% | 111 |
|
|
2023
Q4 | $1.21M | Sell |
2,279
-52
| -2% | -$27.6K | 0.23% | 111 |
|
|
2023
Q3 | $1.18M | Buy |
2,331
+7
| +0.3% | +$3.54K | 0.25% | 104 |
|
|
2023
Q2 | $1.21M | Sell |
2,324
-23
| -1% | -$12K | 0.26% | 89 |
|
|
2023
Q1 | $1.35M | Buy |
2,347
+2
| +0.1% | +$1.15K | 0.34% | 83 |
|
|
2022
Q4 | $1.29M | Buy |
2,345
+13
| +0.6% | +$7.16K | 0.34% | 82 |
|
|
2022
Q3 | $1.18M | Sell |
2,332
-168
| -7% | -$85.2K | 0.33% | 85 |
|
|
2022
Q2 | $1.36M | Buy |
2,500
+3
| +0.1% | +$1.63K | 0.35% | 79 |
|
|
2022
Q1 | $1.48M | Buy |
2,497
+39
| +2% | +$23K | 0.52% | 66 |
|
|
2021
Q4 | $1.64M | Sell |
2,458
-2
| -0.1% | -$1.33K | 0.38% | 68 |
|
|
2021
Q3 | $1.41M | Buy |
2,460
+27
| +1% | +$15.4K | 0.36% | 77 |
|
|
2021
Q2 | $1.23M | Sell |
2,433
-18
| -0.7% | -$9.08K | 0.32% | 82 |
|
|
2021
Q1 | $1.12M | Buy |
2,451
+16
| +0.7% | +$7.31K | 0.3% | 85 |
|
|
2020
Q4 | $1.13M | Buy |
+2,435
| New | +$1.13M | 0.34% | 76 |
|